2009•Di-Si Junyi Daxue xuebaoRequires access

Protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide on the kidney ultrustructure of streptozotocin-induced diabetic nephropathy rats

Jian Ping Yu

Open publisher page 0 citations

Abstract

AIM:To investigate the protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide(ET-1 AS-ODN)on the renal morphology of diabetic nephropathy(DN)and discuss the pathogenesis and mechanism of DN in a diabetic rat model.METHODS:Diabetic rats were induced by intraperitoneal administration of streptozotocin(STZ)at 60 mg/kg.ET-1 AS-ODN was administrated intravenously to the treatment groups and its protective effects on renal morphology were observed.RESULTS:Compared with the DM group,the kidney index reduced significantly the general condition and morphological injury improved significantly in ET-1 AS-ODN treatment groups.CONCLUSION:Endothelin-1 mRNA antisense oligodeoxynucleotide has a protective effect on the kidney by preventing renal impairment in diabetic nephropathy rats.The mechanism of the protective effect of Endothelin-1 mRNA antisense oligodeoxynucleotide involves inhibition of endogenous ET-1 production.

About this research paper

What this paper is about

AIM:To investigate the protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide(ET-1 AS-ODN)on the renal morphology of diabetic nephropathy(DN)and discuss the pathogenesis and mechanism of DN in a diabetic rat model.METHODS:Diabetic rats were induced by intraperitoneal administration of streptozotocin(STZ)at 60 mg/kg.ET-1 AS-ODN was administrated intravenously to the treatment groups and its protective effects on renal morphology were observed.RESULTS:Compared with the DM group,the kidney index reduced significantly the general condition and morphological injury improved significantly in ET-1 AS-ODN treatment groups.CONCLUSION:Endothelin-1 mRNA antisense oligodeoxynucleotide has a protective effect on the kidney by preventing renal impairment in diabetic nephropathy rats.The mechanism of the protective effect of Endothelin-1 mRNA antisense oligodeoxynucleotide involves inhibition of endogenous ET-1 production.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To investigate the protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide(ET-1 AS-ODN)on the renal morphology of diabetic nephropathy(DN)and discuss the pathogenesis and mechanism of DN in a diabetic rat model.METHODS:Diabetic rats were induced by intraperitoneal administration of streptozotocin(STZ)at 60 mg/kg.ET-1 AS-ODN was administrated intravenously to the treatment groups and its protective effects on renal morphology were observed.RESULTS:Compared with the DM group,the kidney index reduced significantly the general condition and morphological injury improved significantly in ET-1 AS-ODN treatment groups.CONCLUSION:Endothelin-1 mRNA antisense oligodeoxynucleotide has a protective effect on the kidney by preventing renal impairment in diabetic nephropathy rats.The mechanism of the protective effect of Endothelin-1 mRNA antisense oligodeoxynucleotide involves inhibition of endogenous ET-1 production.

Key concepts: Streptozotocin, Diabetic nephropathy, Kidney, Endothelin receptor, Intraperitoneal injection, Messenger RNA, Endothelin 1, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide on the kidney ultrustructure of streptozotocin-induced diabetic nephropathy rats — Research Paper | ScholarLens